Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07567794 · ClinicalTrials.gov registry record
GBPDC: Gut-Brain in PD Consortium Master Protocol
A clinical trial, sponsored by Duke University.
- Not yet
- Registry status
- 250
- Enrollment target
NCT07567794 is a clinical trial that has not yet begun recruiting, run by Duke University. The registered enrollment target is 250 participants.
The verdict
NCT07567794 has not yet begun recruiting, sponsored by Duke University.
- NOT YET RECRUITING
- Registry status
- 250 participants
- Enrollment target
Study Summary
The purpose of this research study is to identify the role that the gut-brain axis, the group of nerves that connect the brain and gut, plays in Parkinson's disease (PD). The National Institute of Diabetes and Digestive and Kidney Diseases is sponsoring this research study. During this study, specific groups of participants, also known as "cohorts", will be identified based on the severity of their PD. There will also be a cohort enrolling participants who do not have Parkinson's and a cohort enrolling participants that are at risk for developing PD. Each of these cohorts will be compared to the others to assess the differences in the gut-brain connection. Participants in this study will: * meet with a medical provider * answer questionnaires * give samples of blood, stool, and saliva * have X-rays taken while swallowing different foods (swallowing study) * have X-rays taken to see how long it takes markers to move through their colon (colon transit study) * have a flexible sigmoidoscopy, where a doctor looks inside the lower part of the colon and takes small tissue samples (biopsies) from the mucosa (lining) * have samples taken of their skin * have an anorectal manometry and a balloon expulsion test, where a small tube and balloon are placed in the rectum to measure muscle function. Participation in the study will last up to 24 months (2 years).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2026-06-04 |
| Est. Completion | 2028-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07567794
The ClinicalTrials.gov registry entry for NCT07567794 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07567794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07567794 about?
NCT07567794 is a clinical study titled "GBPDC: Gut-Brain in PD Consortium Master Protocol". The purpose of this research study is to identify the role that the gut-brain axis, the group of nerves that connect the brain and gut, plays in Parkinson's disease (PD). The National Institute of Diabetes and Digestive and Kidney Diseases is sponsoring this research study. During this study, speci...
What is the current status of trial NCT07567794?
This trial is currently not yet recruiting. The enrollment target is 250 participants. The study started on 2026-06-04. Estimated completion is 2028-12-31.
Who is sponsoring clinical trial NCT07567794?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.